IP Library Granted Patent US 7,192,735
Granted Patent B2
US 7,192,735 · App. 10/261,049 · Granted Mar 20, 2007

Phosphopantetheinyl transferases and uses thereof

Assignees: President & Fellows of Harvard College; The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,192,735
App. No.
10/261,049
Granted
Mar 20, 2007
Kind
B2
Abstract

The invention pertains to isolated phosphopantetheinyl transferases, such as the E. coli acyl carrier protein synthase, which transfer a phosphopantetheinyl group onto a substrate. The enzyme can be purified from a natural source, produced recombinantly, or synthetically. Accordingly, the invention provides compositions and kits including phosphopantetheinyl transferases and host cells expressing phosphopantetheinyl transferases. The invention also provides nucleic acids encoding phosphopantetheinyl transferases and vectors comprising such nucleic acids. The invention further provides methods for phosphopantetheinylating a substrate in vitro or in vivo and methods for producing antibiotics in vitro or in vivo.

Claims (23)

1. A method for phosphopantetheinylating a substrate in a cell, comprising transforming the cell with a first nucleic acid molecule comprising an expressible form of a nucleotide sequence encoding a heterologous Bacillus phosphopantetheinyl transferase, and a second nucleic acid molecule comprising an expressible form of a nucleotide sequence encoding a heterologous protein which is a substrate of the phosphopantetheinyl transferase, such that phosphopantetheinylation of the substrate in the cell occurs, wherein the heterologous Bacillus phosphopantetheinyl transferase comprises:

(a) an amino acid sequence of an enzyme selected from the group consisting of Sfi. Psf-1, Gsp and Lpa-14; or

(b) an amino acid sequence at least 90% identical to the amino acid sequence of an enzyme selected from the group consisting of Sfp, Psf-1, Gsp and Lpa-14 and comprising the amino acid sequences set forth in SEQ ID NO: 57 and SEQ ID NO:59,

and wherein the substrate comprises the amino acid sequence shown in SEQ ID NOs: 70 or 71,

and is capable of being phosphopantetheinylated by an enzyme selected from (a) or (b).

2. A method for phosphopantetheinylating a substrate in a cell, comprising transforming the cell with a first nucleic acid molecule comprising an expressible form of a nucleotide sequence encoding a heterologous Bacillus phosphopantetheinyl transferase comprising an amino acid sequence selected from the group consisting of:

(a) an amino acid sequence of Sfp;

(b) an amino acid sequence set forth in SEQ ID NO:8, and

(c) an amino acid sequence at least 90% identical to the amino acid sequence of Sfp and comprising amino acid sequences set forth in SEQ ID NO: 57 and SEQ ID NO:59,

and a second nucleic acid molecule comprising an expressible form of a nucleotide sequence encoding a heterologous protein which is a substrate of the Bacillus phosphopantetheinyl transferase, such that phosphopantetheinylation of the substrate in the cell occurs, wherein the substrate comprises the amino acid sequence shown in SEQ ID NOs:70 or 71, and is capable of being phosphopantetheinylated by the heterologous Bacillus phosphopantetheinyl transferase of (a), (b) or (c).

3. The method of claim 1 , wherein the substrate is a type I acyl carrier protein.

4. The method of claim 1 , wherein the substrate is a type II acyl carrier protein.

5. The method of claim 1 , wherein the cell is selected from the group consisting of a bacterial cell, a yeast cell, a mammalian cell, a plant cell, and an insect cell.

6. The method of claim 1 , wherein the cell is an E. coli cell.

7. The method of claim 1 , wherein the Bacillus phosphopantetheinyl transferase is Sfp.

8. The method of claim 1 , wherein the cell is a yeast cell.

9. The method of claim 1 , wherein the cell is a plant cell.

10. The method of claim 1 , wherein the Bacillus phosphopantetheinyl transferase and the substrate are not naturally expressed in the same cell.

11. The method of claim 1 , wherein the substrate is a protein that is activated by phosphopantetheinylation.

12. The method of claim 1 , or 2 , wherein the heterologous Bacillus phosphopantetheinyl transferase further comprises the amino acid sequence motif 2a as shown in SEQ ID NO:58.

13. The method of claim 1 , or 2 , wherein the heterologous Bacillus phosphopantetheinyl transferase further comprises the amino acid sequence G-X-E (motif 1b), wherein X represents any amino acid residue.

14. The method of claims 1 , or 2 , wherein the amino acid sequences set forth in SEQ ID NOs:57 and 59 are separated by about 45 amino acids.

15. The method of any one of claims 1 , or 2 , wherein the amino acid sequence identity is at least 95%.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 1, 2012
From: HARVARD UNIVERSITY, PRESIDENT AND FELLOW OF HARVARD COLLEGE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029061/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2010
From: GEHRING, AMY MARIE; LAMBALOT, RALPH HAROLD; WALSH, CHRISTOPHER T.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 024517/0302 →
Continuity (4)
Continuation 0872874200 · Oct 11, 1996
Provisional Application 6002165000 · Jul 12, 1996
Provisional Application 6000515200 · Oct 13, 1995
Related Publication 20030138879A1 · Jul 24, 2003